Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

321.18
+1.460.46%
Post-market: 321.180.00000.00%17:37 EST
Volume:491.49K
Turnover:158.03M
Market Cap:13.42B
PE:18.29
High:324.96
Open:318.62
Low:318.01
Close:319.72
52wk High:444.04
52wk Low:293.43
Shares:41.79M
Float Shares:41.27M
Volume Ratio:1.14
T/O Rate:1.19%
Dividend:4.20
Dividend Rate:1.31%
EPS(TTM):17.56
EPS(LYR):28.17
ROE:32.45%
ROA:9.83%
PB:6.74
PE(LYR):11.40

Loading ...

Carlisle Companies Sees FY 2025 Revenues up Low-Single-Digit Percentage Range Year-Over-Year

THOMSON REUTERS
·
Jul 31

Carlisle Companies Inc: Committed to Achieving Vision 2030 Objectives of $40 of Adj EPS and 25% Roic

THOMSON REUTERS
·
Jul 31

CSL Rises 4% to its Highest Since March

MT Newswires Live
·
Jul 22

Carlisle Companies Inc. to Announce Second Quarter 2025 Results

Reuters
·
Jul 17

CSL Shares Fall Amid Target Price Cut by Morgans Financial

MT Newswires Live
·
Jul 11

Bull Says CSL Valued At Less Than Its Main Division -- Market Talk

Dow Jones
·
Jul 11

Morgans Financial Upgrades CSL to Buy from Add; Price Target is AU$303.70

MT Newswires Live
·
Jul 10

CSL Shares Fall as Chairman Comments on Government Efforts to Avoid US Tariffs on Pharmaceuticals

MT Newswires Live
·
Jul 10

ASX Preview: Australian Shares Set to Rise Amid US Rate Cut Optimism; CSL in Focus

MT Newswires Live
·
Jul 10

Neuren Shares Rise, CSL Inches Down After Trump Flags Tariffs on Pharmaceuticals

MT Newswires Live
·
Jul 09

Carlisle Finalizes Purchase of Bonded Logic, Phoenix Fibers Assets

MT Newswires Live
·
Jun 30

Press Release: Carlisle Companies Completes Purchase of Bonded Logic

Dow Jones
·
Jun 30

CSL Finance Names Compliance Chief

MT Newswires Live
·
Jun 26

Carlisle Cos Initiated at Overweight by JP Morgan

Dow Jones
·
Jun 24

CSL Finance's Chief Compliance Officer Resigns

MT Newswires Live
·
Jun 23

Cloudy Outlook for CSL's Vaccines Business in U.S. -- Market Talk

Dow Jones
·
Jun 23

Australian Shares Flat Amid Geopolitical Concerns; CSL's Hereditary Angioedema Drug Secures US FDA Approval

MT Newswires Live
·
Jun 17

Higher Margins Offered by CSL's Andembry Will Lift Earnings -- Market Talk

Dow Jones
·
Jun 17

CSL's Hereditary Angioedema Drug Wins US FDA Approval

MT Newswires Live
·
Jun 17